Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Avita Medical Inc (RCEL)

Avita Medical Inc (RCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avita Medical Inc 28159 Avenue Stanford Suite 220 Valencia CA 91355 USA

www.avitamedical.com P: 661-367-9170

Description:

AVITA Medical Inc. is a regenerative medicine company. It engages in developing and commercializing a technology platform which enables point-of-care autologous skin restoration for multiple unmet needs. AVITA Medical Inc., formerly known as AVITA Therapeutics Inc., is based in VALENCIA, Calif.

Key Statistics

Overview:

Market Capitalization, $K 424,166
Enterprise Value, $K 441,856
Shares Outstanding, K 25,707
Annual Sales, $ 50,140 K
Annual Net Income, $ -35,380 K
Last Quarter Sales, $ 14,200 K
Last Quarter Net Income, $ -7,070 K
EBIT, $ -34,170 K
EBITDA, $ -33,540 K
60-Month Beta 1.39
% of Insider Shareholders 1.96%
% of Institutional Shareholders 27.66%
Float, K 25,203
% Float 98.04%
Short Volume Ratio 0.83

Growth:

1-Year Return 18.48%
3-Year Return -20.94%
5-Year Return -31.96%
5-Year Revenue Growth 809.98%
5-Year Earnings Growth -3.70%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.28 on 02/22/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -1.40
EPS Growth vs. Prev Qtr 17.65%
EPS Growth vs. Prev Year -33.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 06/30/20

RCEL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -54.80%
Return-on-Assets % -38.08%
Profit Margin % -70.56%
Debt/Equity 0.81
Price/Sales 8.20
Price/Cash Flow N/A
Price/Book 8.26
Book Value/Share 1.92
Interest Coverage -29.98
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar